Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$112.7M
10M shares
52-week range
$10.54 – $14.47
9% from low
Sector
SERVICES-MEDICAL LABORATORIES
Exchange
NASDAQ
CS
Borrow rate
2.79%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2024 | 2025 | |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of revenue | $0 | $0 |
| Gross profit | $0 | $0 |
| Gross margin | — | — |
| R&D | $0 | $0 |
| Operating income | −$494.0K | −$3.0M |
| EBITDA | $1.9M | −$3.0M |
| Net income | $1.9M | $837.5K |
| Net margin | — | — |
| EPS (diluted) | 0.30 | 0.08 |
Annual figures · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| PCSCPerceptive Capital Solutions Corp Class A Ordinary Shares | $10.88 | -0.37% | $121M | — |
| CHARCharlton Aria Acquisition Corporation | $10.79 | -0.05% | $115M | — |
| FGMCFG Merger II Corp. | $10.10 | -4.72% | $104M | — |
| KVACKeen Vision Acquisition Corporation Ordinary Shares | $12.32 | +1.15% | $114M | — |
| MAYAMaywood Acquisition Corp. |
Perceptive Capital Solutions Corp is a blank check company.
No one on the platform currently holds PCSC.
No tracked institution reports a position in PCSC as of their last filing.
No one on the platform has traded PCSC yet.
| $10.32 |
| +0.10% |
| $113M |
| — |
| PGACPantages Capital Acquisition Corp | $10.63 | +0.19% | $117M | — |
| QSEAQuartzsea Acquisition Corporation | $10.52 | -0.28% | $120M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$PCSC disclosed that the SEC declared its registration statement effective, clearing the path for its proposed business combination with
View on StockTwits ↗$PCSC looks like they’re requesting an additional year to extend the business combination…
View on StockTwits ↗$PCSC I’ll keep posting here pretending there’s other people on the board. Freenome presenting at NVIDIA conference next week. Could move the needle big on this SPAC. AI x Biotech collab yes plzzzzz
View on StockTwits ↗$PCSC okay. Taking a position next week. I don’t care if it goes down further. I think I’ve seen enough to know this is going to go back up before despac. I could see min 14 again.
View on StockTwits ↗$PCSC presenting at the NVIDIA conference this month.
View on StockTwits ↗$PCSC freenome IPO/merger will multiply this stock price. You are not bullish enough
View on StockTwits ↗$PCSC 25% day will come out of nowhere, start accumulating
View on StockTwits ↗$PCSC Positioning is increasingly shaped by how predictably management executes. Execution risk remains the main variable to watch. Durability across environments would extend investor horizons. Future returns depend more on reliability than ambition.
View on StockTwits ↗$PCSC "We founded PCSC to partner with transformational life sciences companies, and Freenome represents exactly the type of business we set out to support," said Adam Stone, Chief Investment Officer of Perceptive Advisors and CEO of PCSC. "Freenome has built a leading platform, assembled top-tier strategic partners, and demonstrated a clear path toward making blood-based cancer screening broadly accessible. We are thrilled to partner with the Freenome team and to support the company through its next stage of growth.”
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.